P

PLRZ

Polyrizon Ltd

13.42

+0.19+1.44%
After Hours: 13.20  -0.22  -1.64%16:12 06/18 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE13.52/13.23
TODAY RANGE12.50-13.52
VOL66.73K
MARKET CAP27.97M
52 WEEK RANGE2.880-18.20
AVG VOL (3M)44.58K
% TURNOVER3.20%
TURNOVER--
P/E (TTM)-2.7378
% RANGE7.71%
EPS(TTM)-4.9017
P/E(FORWARD)--
P/B1.028
BVPS13.05
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP27.74M
SHARES OUTSTANDING2.08M
NEXT EARNINGS--
FREE FLOAT2.07M
LOT SIZE1
EX-DATE11/28/2025
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

再生元製藥

REGN

+0.33%
609.94

GRDX

--

B

BIONTECH

BNTX

-1.44%
90.89

U

United Therapeutics Corp.

UTHR

-2.70%
536.59

福泰製藥

VRTX

-1.60%
451.63

SIGA

--

M

Moderna

MRNA

+3.50%
63.96

C

Charles Riv Labs Intl Inc

CRL

+1.46%
185.00

M

Medpace Holdings

MEDP

+0.68%
460.20

T

Talphera Inc

TLPH

+12.36%
1.090

I

ICON plc

ICLR

+1.91%
146.00

CBPO

--

IQV

--

M

MOLECULAR PARTNERS AG

MOLN

-2.05%
3.820

A

Arcturus醫療

ARCT

+2.31%
7.53

GILD

--

PRAH

--

INCY

--

A

Aptevo Therapeutics Inc

APVO

-2.71%
4.670

BSTC

--

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.